Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Covington
Citi
Cerilliant
Teva
Chinese Patent Office
Cipla
Mallinckrodt

Generated: April 21, 2018

DrugPatentWatch Database Preview

DIASONE SODIUM Drug Profile

« Back to Dashboard

When do Diasone Sodium patents expire, and what generic alternatives are available?

Diasone Sodium is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in DIASONE SODIUM is sulfoxone sodium. Additional details are available on the sulfoxone sodium profile page.
Drug patent expirations by year for DIASONE SODIUM
Synonyms for DIASONE SODIUM
(Sulfonylbis(p-phenyleneimino))dimethanesulfinic acid disodium salt
[Sulfonylbis(p-phenyleneimino)]dimethanesulfinic acid, disodium salt
144-75-2
4:4'-Diaminodiphenylsulfone disodium formaldehyde sulfoxylate
57OWB0Q221
AC1L1S0J
Adesulfone sodium
Adesulfone Sodium [INN]
AI3-23947
AKOS015913824
Aldapsone
Aldesulfona sodica
Aldesulfona sodica [INN-Spanish]
Aldesulfone [Sodium]
Aldesulfone sodique
Aldesulfone sodique [INN-French]
Aldesulfone sodium
Aldesulfone sodium (INN)
Aldesulfonum natricum
Aldesulfonum natricum [INN-Latin]
Aniline, 4,4'-sulfonyldi-, bis(sodium formaldehydesulfonylate)
Aniline, 4,4'-sulfonyldi-, bis(sodium formaldehydesulfoxylate)
AZBNFLZFSZDPQF-UHFFFAOYSA-L
C14H18N2O6S3
CAS-144-75-2
CHEMBL1200580
D02521
Diamidin
Diasone
Diasone sodium (TN)
Diasone sodium enterab
Diazon
Disodium (sulfonylbis(p-phenyleneimino))dimethanesulfinate
Disodium (sulfonylbis(p-phenylenimino))dimethanesulfinate
DISODIUM [(4-{4-[(SULFINATOMETHYL)AMINO]BENZENESULFONYL}PHENYL)AMINO]METHANESULFINATE
disodium [4-[4-(sulfinatomethylamino)phenyl]sulfonylanilino]methanesulfinate
disodium [sulfonylbis(benzene-4,1-diylimino)]dimethanesulfinate
Disodium diformaldehydesulfoxylate
Disodium formaldehyde sulfoxylate diamino diphenylsulfone
Disodium formaldehydesulfoxylate-diaminodiphenylsulfone
DSSTox_CID_3623
DSSTox_GSID_23623
DSSTox_RID_77116
DTXSID9023623
I14-44600
LS-90060
Methanesulfinic acid, (sulfonylbis(1,4-phenyleneimino))bis-, disodium salt
Methanesulfinic acid, (sulfonylbis(4,1-phenyleneimino))bis-, disodium salt
Methanesulfinic acid, (sulfonylbis(4,1-phenyleneimino))bis-, disodium salt (9CI)
Methanesulfinic acid, (sulfonylbis(p-phenyleneimino))di-, disodium salt
METHANESULFINIC ACID,[SULFONYLBIS(4,1-PHENYLENEIMINO)]BIS-, DISODIUM SALT (9CI)
NCGC00183864-01
Novotrone
NSC 27222
OR073810
OR221636
SCHEMBL155722
Sodium aldesulphone
Sodium sulfoxone
SULFOXONE SODIUM
Sulfoxone sodium [USP]
Tox21_113217
UNII-57OWB0Q221

US Patents and Regulatory Information for DIASONE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DIASONE SODIUM sulfoxone sodium TABLET, DELAYED RELEASE;ORAL 006044-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
QuintilesIMS
Argus Health
Johnson and Johnson
Chinese Patent Office
McKesson
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.